These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37507822)

  • 1. Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments.
    Melchiode Z; Nguyen T; Dawood O; Bobo GA; Hellstrom WJG
    Expert Opin Investig Drugs; 2023; 32(7):635-642. PubMed ID: 37507822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
    Paick JS; Ahn TY; Choi HK; Chung WS; Kim JJ; Kim SC; Kim SW; Lee SW; Min KS; Moon KH; Park JK; Park K; Park NC; Suh JK; Yang DY; Jung HG
    J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Ventimiglia E; Capogrosso P; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016; 15(2):141-52. PubMed ID: 26752541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Du W; Li J; Fan N; Shang P; Wang Z; Ding H
    Aging Male; 2014 Jun; 17(2):107-11. PubMed ID: 24219508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.
    Bruzziches R; Francomano D; Gareri P; Lenzi A; Aversa A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1333-44. PubMed ID: 23675780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
    J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions.
    Ismail EA; El-Sakka AI
    Expert Opin Investig Drugs; 2024 Sep; 33(9):925-938. PubMed ID: 39096237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.
    Paick JS; Kim SW; Yang DY; Kim JJ; Lee SW; Ahn TY; Choi HK; Suh JK; Kim SC
    J Sex Med; 2008 Apr; 5(4):946-953. PubMed ID: 18221288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
    Park HJ; Park JK; Park K; Min K; Park NC
    J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for the treatment of erectile dysfunction.
    Peak TC; Yafi FA; Sangkum P; Hellstrom WJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):263-75. PubMed ID: 25740087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials.
    Ding H; Du W; Wang H; Zhang L; Wang Z; Du C; Tao Y
    Urology; 2012 Jul; 80(1):134-9. PubMed ID: 22497982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 3 Study to Evaluate the 1-Year Efficacy and Safety of Udenafil 75 mg Once Daily in Patients With Erectile Dysfunction.
    Moon KH; Kim SW; Moon du G; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Chung WS; Min KS; Park JK; Yang DY; Shin HS; Park K
    J Sex Med; 2016 Aug; 13(8):1263-9. PubMed ID: 27319276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
    Moon du G; Yang DY; Lee CH; Ahn TY; Min KS; Park K; Park JK; Kim JJ
    J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phosphodesterase type 5 inhibitors clinical efficiency and role in therapy for erectile dysfunction].
    Shodmonova ZR; Gafarov RR; Allazov SA; Giyasov SI
    Urologiia; 2021 May; (2):135-140. PubMed ID: 33960173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avanafil for the treatment of erectile dysfunction.
    Zurawin JL; Stewart CA; Anaissie JE; Yafi FA; Hellstrom WJ
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1163-70. PubMed ID: 27416913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mirodenafil in men taking antihypertensive medications.
    Paick JS; Kim JJ; Kim SC; Moon KH; Min KS; Park K; Suh JK; Yang DY
    J Sex Med; 2010 Sep; 7(9):3143-52. PubMed ID: 20649936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.